Bruce G. Bender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruce G. Bender has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Andrew H. Liu
3 shared publicationsAaron Kobernick
2 shared publicationsAshley A. Lowe
2 shared publicationsBryan Hudson
2 shared publicationsDiane K. King
2 shared publicationsFrederick S. Wamboldt
Department of Psychosocial Medicine, National Jewish Health, Denver, CO; Department of Psychiatry, University of Colorado School of Medicine, Denver, CO
2 shared publications
Latest Publications
- Open Access
- 31 October 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (1)
Outcomes of the Navajo Community Asthma Program during the COVID-19 pandemic
- 31 October 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 5 (1)
Open AccessOutcomes of the Navajo Community Asthma Program during the COVID-19 pandemic
- 30 April 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (8) , 2173-2175.e1
Childhood asthma exacerbations on the Navajo Nation
- 30 April 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (8) , 2173-2175.e1
Childhood asthma exacerbations on the Navajo Nation
- 1 August 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (8) , 3091-3097.e1
The Asthma Toolkit Bootcamp to Improve Rural Primary Care for Pediatric Asthma
- 1 August 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (8) , 3091-3097.e1
The Asthma Toolkit Bootcamp to Improve Rural Primary Care for Pediatric Asthma
- 1 January 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (1) , 339
How Do We Address Food Allergies in High-Risk Populations?
- 1 January 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (1) , 339
How Do We Address Food Allergies in High-Risk Populations?
- 1 January 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (1) , 186-187
Is It Time to Admit Defeat on Patient Adherence?
- 1 January 2020
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (1) , 186-187
Is It Time to Admit Defeat on Patient Adherence?
- Open Access
- 1 January 2019
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 6 (3) , 203-205
Editorial--How Important Are Inhaler Technique Errors?
Treatment of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, depends primarily on inhaled medications. Because of the complexity of inhaled medication delivery, patients' mastery of inhalers presents a major challenge to these treatments. Further, the skill requirements vary across medication devices, including metered-dose inhalers (MDIs), breath-activated MDIs, soft-mist inhalers, drypowder inhalers (DPIs), and nebulizers, adding further potential confusion for both prescribers and patients. A large body of literature has documented the frequency of patient inhaler errors and the correlation of these with worsening outcomes 1 accounting for nearly $900 million in direct and indirect costs. 2 The manuscript by Cho-Reyes et al in this issue of the Journal of the COPD Foundation adds to this literature, combining a systematic review and meta-analysis. Ten previously published reports including 1360 patients revealed that
- 1 January 2019
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 6 (3) , 203-205
Open AccessEditorial--How Important Are Inhaler Technique Errors?
Treatment of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, depends primarily on inhaled medications. Because of the complexity of inhaled medication delivery, patients' mastery of inhalers presents a major challenge to these treatments. Further, the skill requirements vary across medication devices, including metered-dose inhalers (MDIs), breath-activated MDIs, soft-mist inhalers, drypowder inhalers (DPIs), and nebulizers, adding further potential confusion for both prescribers and patients. A large body of literature has documented the frequency of patient inhaler errors and the correlation of these with worsening outcomes 1 accounting for nearly $900 million in direct and indirect costs. 2 The manuscript by Cho-Reyes et al in this issue of the Journal of the COPD Foundation adds to this literature, combining a systematic review and meta-analysis. Ten previously published reports including 1360 patients revealed that
- Open Access
- 8 November 2018
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 52 (5) , 1801147
Digital technologies and adherence in respiratory diseases: the road ahead
Outcomes for patients with chronic respiratory diseases remain poor despite the development of novel therapies. In part, this reflects the fact that adherence to therapy is low and clinicians lack accurate methods to assess this issue. Digital technologies hold promise to overcome these barriers to care. For example, algorithmic analysis of large amounts of information collected on health status and treatment use, along with other disease relevant information such as environmental data, can be used to help guide personalised interventions that may have a positive health impact, such as establishing habitual and correct inhaler use. Novel approaches to data analysis also offer the possibility of statistical algorithms that are better able to predict exacerbations, thereby creating opportunities for preventive interventions that may adapt therapy as disease activity changes. To realise these possibilities, digital approaches to disease management should be supported by strong evidence, have a solid infrastructure, be designed collaboratively as clinically effective and cost-effective systems, and reflect the needs of patients and healthcare providers. Regulatory standards for digital interventions and strategies to handle the large amounts of data generated are also needed. This review highlights the opportunities provided by digital technologies for managing patients with respiratory diseases.
- 8 November 2018
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 52 (5) , 1801147
Open AccessDigital technologies and adherence in respiratory diseases: the road ahead
Outcomes for patients with chronic respiratory diseases remain poor despite the development of novel therapies. In part, this reflects the fact that adherence to therapy is low and clinicians lack accurate methods to assess this issue. Digital technologies hold promise to overcome these barriers to care. For example, algorithmic analysis of large amounts of information collected on health status and treatment use, along with other disease relevant information such as environmental data, can be used to help guide personalised interventions that may have a positive health impact, such as establishing habitual and correct inhaler use. Novel approaches to data analysis also offer the possibility of statistical algorithms that are better able to predict exacerbations, thereby creating opportunities for preventive interventions that may adapt therapy as disease activity changes. To realise these possibilities, digital approaches to disease management should be supported by strong evidence, have a solid infrastructure, be designed collaboratively as clinically effective and cost-effective systems, and reflect the needs of patients and healthcare providers. Regulatory standards for digital interventions and strategies to handle the large amounts of data generated are also needed. This review highlights the opportunities provided by digital technologies for managing patients with respiratory diseases.
- 1 July 2018
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 121 (1) , 24-30
Where does health communication technology fit into allergy practice?
- 1 July 2018
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 121 (1) , 24-30
Where does health communication technology fit into allergy practice?
- 1 May 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (3) , 895-896
Primary Care Guideline Nonadherence: Ignorance or Reasonable Doubt?
- 1 May 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (3) , 895-896
Primary Care Guideline Nonadherence: Ignorance or Reasonable Doubt?
- 1 May 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (3) , 794-800
Technology Interventions for Nonadherence: New Approaches to an Old Problem
- 1 May 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (3) , 794-800
Technology Interventions for Nonadherence: New Approaches to an Old Problem